US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gilead Sciences

106.38

+0.87000.82%

Pre-market: 106.380.00000.00%08:15 EDT

Volume:8.18M

Turnover:867.03M

Market Cap:132.62B

PE:279.95

High:106.64

Open:105.95

Low:99.32

Close:105.51

Loading ...

Overview Company News Filings

Gilead Sciences: New Prep Modality Preference Data Shows Preference for Twice-Yearly Lenacapavir VS Once Daily Orals in Purpose 1 Survey Participants

THOMSON REUTERS

First Clinical Data for Gilead’s Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet

Gilead Sciences Presents First Clinical Data for Investigational Once-Yearly Lenacapavir for Hiv Prevention

THOMSON REUTERS

Gilead Sciences: Safety Data Showed Both Formulations of Once-Yearly Lenacapavir for Prep Were Well Tolerated, With No New Safety Signals

THOMSON REUTERS

KOD Completes Enrollment in Phase III Study for Eye Disease Candidate

Gilead Sciences Inc. : Morgan Stanley Raises Target Price to $130.00 From $123.00

THOMSON REUTERS

Buy 5 Non-Tech High-Flying Nasdaq Stocks Amid Index's Recent Bloodbath

Morgan Stanley Adjusts Price Target on Gilead Sciences to $130 From $123, Keeps Overweight Rating

MT Newswires Live

Gilead Sciences Is Maintained at Overweight by Morgan Stanley

Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks

S&P 500 ETF's Worst Week Since September: 5 Top Stocks Poised to Rise

Zacks Investment Ideas feature highlights: Gilead Sciences and Johnson & Johnson

INCY Opzelura Shows Superior Efficacy in 2 Prurigo Nodularis Studies

EC Approves Bristol Myers' Opdivo Plus Yervoy for First-Line HCC

Is Gilead Sciences (GILD) Stock Outpacing Its Medical Peers This Year?

LLY/INCY Olumiant Shows Superior Efficacy in Pediatric Alopecia Study

1 Value Stock with Exciting Potential and 2 to Ignore

Krystal Biotech Rises 15.8% in a Month: Should You Buy Now or Wait?

Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day

Buy Gilead Sciences (GILD) Stock at 52-Week Highs?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GILD/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GILD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GILD\",,,,,undefined,":{"symbol":"GILD","market":"US","secType":"STK","nameCN":"Gilead Sciences","latestPrice":106.38,"timestamp":1745438400000,"preClose":105.51,"halted":0,"volume":8178745,"hourTrading":{"tag":"盘前","latestPrice":106.38,"preClose":106.38,"latestTime":"08:15 EDT","volume":1050,"amount":112217.54250000001,"timestamp":1745496956754},"delay":0,"floatShares":1243965050,"shares":1246634469,"eps":0.38,"marketStatus":"Pre-Mkt","change":0.87,"latestTime":"04-24 08:16:31 EDT","open":105.95,"high":106.635,"low":99.32,"amount":867030556.7739,"amplitude":0.06933,"askPrice":106.64,"askSize":1,"bidPrice":106.23,"bidSize":7,"shortable":3,"etf":0,"ttmEps":0.38,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745501400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":696056400000,"exchange":"NASDAQ","adjPreClose":106.38,"dividendRate":0.028953,"preHourTrading":{"tag":"盘前","latestPrice":106.38,"preClose":106.38,"latestTime":"08:15 EDT","volume":1050,"amount":112217.54250000001,"timestamp":1745496956754},"postHourTrading":{"tag":"盘后","latestPrice":106.5699,"preClose":106.41,"latestTime":"19:59 EDT","volume":608265,"amount":64707953.2899,"timestamp":1745452771324},"volumeRatio":1.1045835989819988,"optionData":{"bulkOrders":[{"symbol":"GILD","call":false,"expireDate":1747368000000,"strike":"80.0","timestamp":1745430169395,"price":0.2,"volume":1570,"amount":31400,"type":"+"}]},"impliedVol":0.4002,"impliedVolPercentile":0.9438},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GILD\",,,,,undefined,":{"symbol":"GILD","floatShares":1243965050,"roa":"11.03%","roe":"2.29%","lyrEps":0.384923,"volumeRatio":1.1045835989819988,"shares":1246634469,"dividePrice":3.08,"high":106.635,"amplitude":0.06933,"preClose":105.51,"low":99.32,"week52Low":62.07,"pbRate":"6.86","psRate":"4.61","week52High":119.96,"institutionHeld":0.7997,"latestPrice":106.38,"committee":0.75,"eps":0.38,"divideRate":0.028953,"volume":8178745,"delay":0,"ttmEps":0.38,"open":105.95,"prevYearClose":92.37,"prevWeekClose":104.54,"prevMonthClose":112.05,"prevQuarterClose":112.05,"fiveDayClose":105.68,"twentyDayClose":107.89,"sixtyDayClose":95.35},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GILD\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518727112","title":"Gilead Sciences: New Prep Modality Preference Data Shows Preference for Twice-Yearly Lenacapavir VS Once Daily Orals in Purpose 1 Survey Participants","url":"https://stock-news.laohu8.com/highlight/detail?id=2518727112","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518727112?lang=en_us&edition=fundamental","pubTime":"2025-03-12 01:37","pubTimestamp":1741714620,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nP8N3M007C:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","LU0289739699.SGD","LU2089984988.USD","IE00B7SZLL34.SGD","BK4139","LU1066053197.SGD","LU1430594728.SGD","BK4568","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU1839511570.USD","BK4583","IE00B19Z3B42.SGD","LU1571399168.USD","LU0889565916.HKD","LU1585245621.USD","BK4585","LU0234570918.USD","IE00BZ1G4Q59.USD","IE00B3T34201.USD","IE0002270589.USD","LU1066051498.USD","LU0320765992.SGD","LU2087621335.USD","BK4578","BK4588","BK4566","LU0109394709.USD","GILD","IE00B19Z3581.USD","BK4550","LU0058720904.USD","LU2468319806.SGD"],"gpt_icon":0},{"id":"2518472074","title":"First Clinical Data for Gilead’s Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet","url":"https://stock-news.laohu8.com/highlight/detail?id=2518472074","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518472074?lang=en_us&edition=fundamental","pubTime":"2025-03-12 01:37","pubTimestamp":1741714620,"startTime":"0","endTime":"0","summary":"– Phase 1 Data Indicate Potential for Use of Once-Yearly Lenacapavir for HIV Prevention, with Plans to Launch a Phase 3 Trial in 2H 2025 –。FOSTER CITY, Calif., March 11, 2025----Gilead Sciences, Inc.  today presented the first data from its ongoing Phase 1 study investigating two novel, once-yearly formulations of lenacapavir, the company’s injectable HIV-1 capsid inhibitor, for the investigational use of HIV prevention as pre-exposure prophylaxis . The data were presented during an oral abstract session at the Conference on Retroviruses and Opportunistic Infections  and were also published today in The Lancet. Data will support the future development of once-yearly lenacapavir for PrEP, for which Gilead plans to launch a Phase 3 study in the second half of 2025.\"Gilead is continuing to innovate in our work to develop additional person-centered long-acting injectable and oral options to help people find an HIV prevention choice that is right for them,\" said Jared Baeten, MD, PhD, Senio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/first-clinical-data-gilead-investigational-173700198.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4568","LU1430594728.SGD","BK4578","BK4588","LU0234570918.USD","IE00BKVL7J92.USD","LU1066051498.USD","LU1066053197.SGD","IE00B3T34201.USD","IE00B19Z3581.USD","LU0320765992.SGD","LU2089984988.USD","LU0889565916.HKD","IE0002270589.USD","LU1571399168.USD","IE00B19Z3B42.SGD","BK4139","LU1585245621.USD","LU2468319806.SGD","IE00BSNM7G36.USD","LU0058720904.USD","LU1839511570.USD","BK4532","LU2087621335.USD","BK4550","LU0289739699.SGD","BK4566","IE00BZ1G4Q59.USD","IE00B7SZLL34.SGD","LU0109394709.USD","BK4585","GILD","BK4583"],"gpt_icon":0},{"id":"2518172711","title":"Gilead Sciences Presents First Clinical Data for Investigational Once-Yearly Lenacapavir for Hiv Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=2518172711","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518172711?lang=en_us&edition=fundamental","pubTime":"2025-03-12 01:37","pubTimestamp":1741714620,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nP8N3M007C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GILD","LU2089984988.USD","BK4568","BK4139","LU1571399168.USD","LU2468319806.SGD","IE00B19Z3581.USD","LU0058720904.USD","LU1839511570.USD","LU0109394709.USD","LU2087621335.USD","LU0289739699.SGD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","BK4566","IE00B7SZLL34.SGD","LU0889565916.HKD","LU1430594728.SGD","BK4588","BK4585","IE0002270589.USD","LU0320765992.SGD","LU0234570918.USD","IE00B3T34201.USD","LU1066053197.SGD","LU1585245621.USD","LU1066051498.USD","BK4583","BK4532","BK4550","BK4578"],"gpt_icon":0},{"id":"2518146727","title":"Gilead Sciences: Safety Data Showed Both Formulations of Once-Yearly Lenacapavir for Prep Were Well Tolerated, With No New Safety Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=2518146727","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518146727?lang=en_us&edition=fundamental","pubTime":"2025-03-12 01:37","pubTimestamp":1741714620,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nP8N3M007C:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1839511570.USD","IE00B3T34201.USD","BK4139","GILD","LU1585245621.USD","IE00B7SZLL34.SGD","LU2089984988.USD","LU2087621335.USD","IE00BSNM7G36.USD","BK4578","LU1066051498.USD","BK4566","BK4568","LU1066053197.SGD","BK4583","LU0889565916.HKD","BK4550","LU0234570918.USD","LU1571399168.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","IE0002270589.USD","LU0058720904.USD","BK4585","LU1430594728.SGD","BK4532","LU2468319806.SGD","IE00B19Z3581.USD","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","LU0109394709.USD","BK4588","LU0320765992.SGD"],"gpt_icon":0},{"id":"2518072238","title":"KOD Completes Enrollment in Phase III Study for Eye Disease Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2518072238","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518072238?lang=en_us&edition=fundamental","pubTime":"2025-03-11 22:39","pubTimestamp":1741703940,"startTime":"0","endTime":"0","summary":"Kodiak SciencesKOD announced that it has completed enrollment in a late-stage study of tarcocimab tedromer in patients with diabetic retinopathy . Per KOD, more than 250 patients have been enrolled in the phase III GLOW2 study, surpassing the initial enrollment target. With a 48-week treatment duration, all patients are expected to complete their primary endpoint visits by the end of January 2026. The top-line clinical data is anticipated to be announced in the first quarter of 2026.In late 2023, Kodiak rebooted the development program of tarcocimab following positive phase III results from the GLOW1 study, which evaluated the treatment in patients with moderately severe to severe non-proliferative diabetic retinopathy. Leveraging the GLOW1 study's success, Kodiak initiated the GLOW2 study to further investigate tarcocimab for DR and began dosing patients in May 2024. Enrolled DR patients will receive tarcocimab on extended dosing intervals, including six-month dosing for all patients.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kod-completes-enrollment-phase-iii-143900570.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2458330169.SGD","LU1923623000.USD","LU2360106780.USD","KOD","IE00B3T34201.USD","LU0109394709.USD","LU0082616367.USD","IE00B19Z3581.USD","LU2250418816.HKD","LU1316542783.SGD","BK4573","LU0320765992.SGD","BK4554","LU0719512351.SGD","LU2054465674.USD","BK4575","BK4578","BK4612","CORT","LU1803068979.SGD","GILD","IE0009356076.USD","BK4141","IE00BSNM7G36.USD","LU0642271901.SGD","LU1988902786.USD","IE00B19Z3B42.SGD","LU2468319806.SGD","LU1559883803.SGD","BK4614","BMRN","LU2089984988.USD","BK4585","LU0889565833.HKD","LU1066051498.USD","LU2098885051.SGD","LU1839511570.USD","BK4583","LU0889565916.HKD","LU0390134368.USD","LU1951198990.SGD","LU0056508442.USD","LU0823434583.USD","III","LU0127658192.USD","LU1880398554.USD","LU2458330243.SGD","LU1951200564.SGD","BK4550"],"gpt_icon":1},{"id":"2518740402","title":"Gilead Sciences Inc. : Morgan Stanley  Raises Target Price to $130.00 From $123.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2518740402","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518740402?lang=en_us&edition=fundamental","pubTime":"2025-03-11 21:55","pubTimestamp":1741701349,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nAZN3JKIEA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B3T34201.USD","LU0889565916.HKD","LU1571399168.USD","LU0109394709.USD","IE0002270589.USD","LU0320765992.SGD","LU2468319806.SGD","LU0058720904.USD","IE00BZ1G4Q59.USD","BK4578","LU0289739699.SGD","LU1066051498.USD","BK4568","LU2089984988.USD","BK4139","GILD","BK4550","LU2087621335.USD","BK4583","LU1430594728.SGD","IE00B19Z3581.USD","BK4566","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","BK4585","LU1839511570.USD","IE00BKVL7J92.USD","LU1585245621.USD","BK4532","BK4588","LU1066053197.SGD","IE00BSNM7G36.USD","LU0234570918.USD"],"gpt_icon":0},{"id":"2518728824","title":"Buy 5 Non-Tech High-Flying Nasdaq Stocks Amid Index's Recent Bloodbath","url":"https://stock-news.laohu8.com/highlight/detail?id=2518728824","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518728824?lang=en_us&edition=fundamental","pubTime":"2025-03-11 21:12","pubTimestamp":1741698720,"startTime":"0","endTime":"0","summary":"Wall Street’s high-flying northward journey from January 2023 to January 2025 was predominantly supported by an astonishing rally in the technology sector, buoyed by the explosive growth of generative artificial intelligence . Several AI-centric stocks skyrocketed 400-500% during this period.As many financial experts and economists expect a near-term recession, investors are gradually booking profits in tech stocks, for which valuations are extremely overstretched. The three major stock indexes — the Dow, the S&P 500 and the Nasdaq Composite — are in negative territory year to date.The Nasdaq Composite is currently in correction territory, sliding 14% from its recent high. The S&P 500 is also 8.7% below its recent high. An index enters correction territory once it falls below 10% of its recent high. Despite the index’s recent bloodbath, a handful of non-tech Nasdaq Composite listed stocks have provided double-digit returns year to date. At this juncture, investing in these stocks shoul","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/buy-5-non-tech-high-131200771.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TSYW.SI","SPY","QID","NDAQ","SDS","OEF","ESmain","ROE","PAA","LU2506952170.USD","PSQ",".SPX","BK4532","MNQmain",".IXIC","US2Y.BOND","US7Y.BOND","US3Y.BOND","BK4606","USJW.SI","COMP","GILD","IE00BZ1G4Q59.USD","SH","SQQQ","SRAD","TQQQ","US5Y.BOND","USAW.SI","UPRO","EXC","BK4534","QLD","IE00BKVL7J92.USD","LU0251142724.SGD","SPXU","IE00BGHQF748.EUR","VOO","US6M.BOND","OEX","CTAS","NVIW.SI","NQmain","US30Y.BOND","BK4112","US10Y.BOND","US12M.BOND","IVV","SSO"],"gpt_icon":1},{"id":"2518104837","title":"Morgan Stanley Adjusts Price Target on Gilead Sciences to $130 From $123, Keeps Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2518104837","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518104837?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:47","pubTimestamp":1741693659,"startTime":"0","endTime":"0","summary":"Gilead Sciences (GILD) has an average rating of overweight and mean price target of $113.09, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from m","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GILD"],"gpt_icon":0},{"id":"2518671455","title":"Gilead Sciences Is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2518671455","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518671455?lang=en_us&edition=fundamental","pubTime":"2025-03-11 18:56","pubTimestamp":1741690560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GILD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 11, 2025 06:56 ET (10:56 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD"],"gpt_icon":0},{"id":"2518719948","title":"Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2518719948","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518719948?lang=en_us&edition=fundamental","pubTime":"2025-03-11 17:03","pubTimestamp":1741683790,"startTime":"0","endTime":"0","summary":"As the craze of earnings season draws to a close, here’s a look back at some of the most exciting  results from Q4. Today, we are looking at therapeutics stocks, starting with Myriad Genetics .Over the next few years, therapeutic companies, which develop a wide variety of treatments for diseases and disorders, face strong tailwinds from advancements in precision medicine  and growing demand for treatments targeting rare diseases. However, headwinds such as rising scrutiny over drug pricing, regulatory unknowns, and competition from larger, more resourced pharmaceutical companies could weigh on growth.The 10 therapeutics stocks we track reported a satisfactory Q4. As a group, revenues beat analysts’ consensus estimates by 2.6%.Thankfully, share prices of the companies have been resilient as they are up 5.2% on average since the latest earnings results.Founded in 1991, Myriad Genetics  provides genetic testing and precision medicine solutions, with a focus on identifying hereditary risks","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/winners-losers-q4-myriad-genetics-090310721.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0738911758.USD","LU1732800096.USD","LU0689472784.USD","BK4139","LU1989771016.USD","SQQQ","BK4568","NDAQ","LU1496350171.SGD","ABT",".IXIC","TQQQ","LU1267930490.SGD","LU0198837287.USD","LU0965508806.USD","LU1037948897.HKD","LU1989763690.USD","LU1291159041.SGD","QID","USAW.SI","LU1934455194.USD","NVIW.SI","BMRN","SG9999001440.SGD","ABBV","LU0170899867.USD","USJW.SI","MYGN","GILD","QLD","MNQmain","LU0882574055.USD","LU1066051498.USD","LU0456855351.SGD","TSYW.SI","LU0820561818.USD","LENZ","IE00BZ1G4Q59.USD","IE0002141913.USD","IE00B2B36J28.USD","PSQ","LU0320765992.SGD","LU0661504455.SGD","NQmain","IE00BGHQF631.EUR","LU2210150020.SGD","BK4112","LU1093756325.SGD"],"gpt_icon":1},{"id":"2518209147","title":"S&P 500 ETF's Worst Week Since September: 5 Top Stocks Poised to Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2518209147","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518209147?lang=en_us&edition=fundamental","pubTime":"2025-03-11 01:00","pubTimestamp":1741626000,"startTime":"0","endTime":"0","summary":"Wall Street was downbeat last week, with the S&P 500 losing 3.1%, the Dow Jones shedding about 2.4% and the Nasdaq Composite retreating 3.5%. The S&P 500 recorded its worst week since September 2024. SPDR S&P 500 ETF Trust SPY lost 3.4% in the week. The Nasdaq officially entered correction territory — defined as a 10% decline from recent highs.Investors largely shrugged off a weaker-than-expected February jobs report, which briefly pushed Treasury yields lower. Nonfarm payrolls increased by 151,000 in February, falling short of economists' expectations of 170,000. The unemployment rate rose to 4.1%, adding to concerns about economic softening.The week’s market turmoil was driven by concerns over trade policy. President Donald Trump’s tariff announcements created uncertainty, though he later exempted goods from Canada and Mexico under the USMCA until April 2. This partially reversed the original plan, but markets still struggled with a lack of long-term clarity.The Zacks Rank #2 Charter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/p-500-etfs-worst-week-170000500.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OEX","IE00B7SZLL34.SGD","LU1923621640.USD",".SPX","SPXU","LU0289739699.SGD","LU2125910179.SGD","LU1620156130.USD","ESmain","LU2413666426.HKD","LU0208291251.USD","GILD","BK4578","CHTR","LU0070302665.USD","LU0320765992.SGD","LU2413666699.HKD","ERIE","IE00BD4GTW91.USD","IE00BZ1G4Q59.USD","JKHY","LU0058720904.USD","SDS","COMP","SH","BK4534","BK4139","LU0477156953.USD","LU0175139822.USD","SSO","IVV","IE00B3T34201.USD","SPY","LU1201861249.SGD","BK4532","LU1066051498.USD","FDN","LU0347712357.USD","UPRO","IE00BD4GTT62.SGD","LU0289960550.SGD","IE0002270589.USD","LU0648000940.SGD","LU0889565916.HKD","BK4227","LU2413665964.HKD","AWK","LU1721428933.USD","OEF","VOO"],"gpt_icon":0},{"id":"2518527796","title":"Zacks Investment Ideas feature highlights: Gilead Sciences and Johnson & Johnson","url":"https://stock-news.laohu8.com/highlight/detail?id=2518527796","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518527796?lang=en_us&edition=fundamental","pubTime":"2025-03-10 23:02","pubTimestamp":1741618920,"startTime":"0","endTime":"0","summary":"Chicago, IL – March 10, 2025– Today, Zacks Investment Ideas feature highlights Gilead Sciences GILD and Johnson & Johnson JNJ.Medical pioneer Gilead Sciences has seen its stock etch out new 52-week highs as the broader market pulled back sharply in recent weeks. Gilead has joined Johnson & Johnson, and a cluster of healthcare stocks that have risen to fresh peaks.This makes it a worthy topic of whether Gilead's stock can reach higher highs with investors scoping out exposure to the medical sector amid economic uncertainty. Trading at $117 a share, GILD has spiked nearly +30% year to date with the broader market indexes in negative territory.Bringing in $28.75 billion in 2024, Gilead's top line is expected to dip 1% this year but is projected to rebound and rise 4% in fiscal 2026 to $29.7 billion.More intriguing, Gilead's operational efficiency has led the company and its stock back to prominence. Gilead's annual earnings are expected to soar 70% in FY25 to $7.87 per share compared to E","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-investment-ideas-feature-highlights-150200009.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B1BXHZ80.USD","LU1506573853.SGD","LU0889565916.HKD","JNJ","LU0889566641.SGD","LU1571399168.USD","LU1778281490.HKD","IE0002270589.USD","LU0912757837.SGD","LU1066051225.USD","BK4581","LU0114720955.EUR","LU1732799900.SGD","IE000M9KFDE8.USD","LU2468319806.SGD","LU1074936037.SGD","BK4578","LU1023059063.AUD","LU1032466523.USD","LU2089984988.USD","BK4568","IE00BDGV0183.EUR","LU0345770993.USD","GILD","LU1244550577.SGD","LU1066051811.HKD","LU0122379950.USD","BK4550","LU2087621335.USD","LU0882574055.USD","LU2602419157.SGD","LU2112291526.USD","LU0795875169.SGD","IE00B19Z3581.USD","LU1894683348.USD","BK4566","BK4585","LU0345769631.USD","LU0345769128.USD","BK4533","LU1839511570.USD","IE00BKVL7J92.USD","LU1585245621.USD","LU0203345920.USD","LU0466842654.USD","BK4588","LU0203347892.USD","LU0234570918.USD","SG9999001440.SGD","BK4559"],"gpt_icon":0},{"id":"2518565270","title":"INCY Opzelura Shows Superior Efficacy in 2 Prurigo Nodularis Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2518565270","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518565270?lang=en_us&edition=fundamental","pubTime":"2025-03-10 22:52","pubTimestamp":1741618320,"startTime":"0","endTime":"0","summary":"IncyteINCY announced positive results from two late-stage studies evaluating the safety and efficacy of its twice-daily ruxolitinib cream 1.5% in adults with prurigo nodularis . The data readout from both studies was recently presented at the 2025American Academy of Dermatology Annual Meeting.PN is a chronic inflammatory skin condition causing intense itching and thickened red nodules, primarily on the arms, legs, and trunk. Affecting around 200,000 people in the United States, it is most common in individuals aged 40-69. Persistent scratching leads to nodules, significantly impacting sleep and overall quality of life.Please note that ruxolitinib cream 1.5%, a topical JAK1/2 inhibitor, is currently approved in the United States under the brand name Opzelura for treating nonsegmental vitiligo in patients aged 12 and older. It is also approved for short-term and non-continuous chronictreatment of mild to moderate atopic dermatitis in non-immunocompromised patients of the same age group w","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/incy-opzelura-shows-superior-efficacy-145200413.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1430594728.SGD","GILD","BK4550","IE0002270589.USD","LU0320765992.SGD","IE00B7SZLL34.SGD","BK4578","LU0889565916.HKD","LU0109394709.USD","BK4568","BK4532","CORT","BK4566","BK4585","IE00B19Z3B42.SGD","LU1839511570.USD","LU0058720904.USD","LU2089984988.USD","IE00BZ1G4Q59.USD","LU2087621335.USD","IE00B19Z3581.USD","BK4007","LU1066053197.SGD","PN","LU0289739699.SGD","INCY","LU1559883803.SGD","LU2468319806.SGD","LU0234570918.USD","BMRN","BK4588","IE00BSNM7G36.USD","BK4139","LU0566484027.USD","LU1585245621.USD","IE00B3T34201.USD","LU1066051498.USD","BK4583","IE00BKVL7J92.USD","LU1571399168.USD"],"gpt_icon":0},{"id":"2518277677","title":"EC Approves Bristol Myers' Opdivo Plus Yervoy for First-Line HCC","url":"https://stock-news.laohu8.com/highlight/detail?id=2518277677","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518277677?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:41","pubTimestamp":1741614060,"startTime":"0","endTime":"0","summary":"Bristol Myers BMY announced that the European Commission  has approved the blockbuster immuno-oncology drug Opdivo  plus Yervoy  for the first-line treatment of adult patients with unresectable or advanced hepatocellular carcinoma , a type of liver cancer.This approval is based on results of phase III CheckMate -9DW clinical study demonstrating a statistically significant and clinically meaningful improvement in overall survival with Opdivo plus Yervoy compared to investigator’s choice of Lenvima  or Nexavar .HCC accounts for 90% of liver cancer cases worldwide, which is the third most frequent cause of cancer death.In August 2024, the FDA also accepted BMY’s supplemental biologics license application  for Opdivo plus Yervoy as a potential first-line treatment option for adult patients with unresectable HCC and assigned a target action date of April 21, 2025.We note that the FDA granted accelerated approval in 2020 for the combination of Opdivo plus Yervoy as a second-line treatment fo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ec-approves-bristol-myers-opdivo-134100082.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4566","LU1868836914.USD","LU2242646821.SGD","LU0321505439.SGD","BK4139","LU2360032135.SGD","LU0109394709.USD","LU2125154778.USD","LU1032466523.USD","LU1430594728.SGD","IE00BJT1NW94.SGD","LU0225771236.USD","BK4532","LU1670710588.SGD","EC","LU0889565916.HKD","LU0882574055.USD","LU1074936037.SGD","LU1868837136.USD","IE00BZ1G4Q59.USD","LU2468319806.SGD","BK4126","LU1670710661.SGD","BMRN","IE00B19Z3581.USD","LU0985481810.HKD","GILD","LU0306807586.USD","BK4559","LU0306806265.USD","IE00B2B36J28.USD","HCC","BK4007","LU0289739699.SGD","LU1868837300.USD","LU0320765992.SGD","MYE","IE0009355771.USD","IE00BSNM7G36.USD","BMY","BK4568","LU2089984988.USD","LU1261432733.SGD","LU0061475181.USD","LU1093756325.SGD","LU1323610961.USD","LU0237698245.USD","BK4578","LU0321505868.SGD","LU1093756168.USD"],"gpt_icon":0},{"id":"2518271386","title":"Is Gilead Sciences (GILD) Stock Outpacing Its Medical Peers This Year?","url":"https://stock-news.laohu8.com/highlight/detail?id=2518271386","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518271386?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:40","pubTimestamp":1741614010,"startTime":"0","endTime":"0","summary":"For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Gilead Sciences  is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole?Let's take a closer look at the stock's year-to-date performance to find out.Gilead Sciences is a member of our Medical group, which includes 1012 different companies and currently sits at #4 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Gilead Sciences is currently sporting a Zacks Rank of #2 .Gilead Sciences, Inc.  : Free Stock Analysi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gilead-sciences-gild-stock-outpacing-134010049.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1430594728.SGD","LU1585245621.USD","LU0889565916.HKD","LU0058720904.USD","BK4588","LU2087621335.USD","BK4532","BK4568","IE00BSNM7G36.USD","ANIX","IE00B19Z3B42.SGD","LU0234570918.USD","IE00B19Z3581.USD","LU0289739699.SGD","LU0109394709.USD","IE00BZ1G4Q59.USD","GILD","LU2089984988.USD","LU1571399168.USD","BK4585","LU1066053197.SGD","IE00B3T34201.USD","BK4566","IE0002270589.USD","LU1839511570.USD","IE00BKVL7J92.USD","BK4578","IE00B7SZLL34.SGD","BK4550","LU2468319806.SGD","LU0320765992.SGD","BK4139","BK4583","LU1066051498.USD"],"gpt_icon":0},{"id":"2518781082","title":"LLY/INCY Olumiant Shows Superior Efficacy in Pediatric Alopecia Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2518781082","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518781082?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:13","pubTimestamp":1741612380,"startTime":"0","endTime":"0","summary":"Eli LillyLLY and partner Incyte INCY announced that a late-stage study evaluating oral baricitinib in adolescent patients  with severe alopecia areata  showed clinically meaningful improvements in hair regrowth on the scalp, eyebrows and eyelashes at Week 36.The phase III BRAVE-AA-PEDS study enrolled 257 patients who were randomized to receive either a dose of baricitinib  or placebo.AA is an immune system disorder that leads to patchy hair loss on the scalp, face, and occasionally other parts of the body, with the potential to worsen over time. Around 40% of individuals with AA experience their first onset by the age of 20.LLY/INCY’s Phase III Alopecia Study Data in Detail. Lilly reported that 60% of patients receiving Olumiant 4 mg and 36.9% receiving Olumiant 2 mg experienced at least a 50% improvement in their condition, as measured by SALT score  compared to 5.7% on placebo. Additionally, 42.4% of patients receiving the 4 mg dose and 27.4% receiving the 2 mg dose achieved at least","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lly-incy-olumiant-shows-superior-131300949.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BFTCPJ56.SGD","LU2089984988.USD","IE00B4R5TH58.HKD","SGXZ31699556.SGD","INCY","LU0466842654.USD","BK4599","IE00BSNM7G36.USD","LU0109391861.USD","LU1366192091.USD","LU2491050154.USD","BK4583","GILD","IE00B2B36J28.USD","LU0820561818.USD","LU2468319806.SGD","BK4588","BK4007","BMRN","BK4566","LU2237443549.SGD","LU0320765992.SGD","LU0823416689.USD","LU1280957306.USD","LU2361045086.USD","IE00B1BXHZ80.USD","SG9999014914.USD","LLY","LU1551013342.USD","LU1069344957.HKD","GB00BDT5M118.USD","LU2237443382.USD","LU0061475181.USD","LU1057294990.SGD","SG9999018857.SGD","LU0106261372.USD","LU0354030511.USD","LU0114720955.EUR","LU1983299246.USD","LU1548497426.USD","IE0002270589.USD","LU0203201768.USD","LU1430594728.SGD","LU2237443978.SGD","LU2491050071.SGD","LU1720051017.SGD","BK4533","BK4578","SGXZ51526630.SGD","AA"],"gpt_icon":1},{"id":"2518682278","title":"1 Value Stock with Exciting Potential and 2 to Ignore","url":"https://stock-news.laohu8.com/highlight/detail?id=2518682278","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518682278?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:01","pubTimestamp":1741611660,"startTime":"0","endTime":"0","summary":"Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.This distinction between true value and value traps can challenge even the most skilled investors. Luckily for you, we started StockStory to help you uncover exceptional companies. Keeping that in mind, here is one value stock trading at a big discount to its intrinsic value and two with little support.Originally started as a joint venture between several media companies including The Washington Post and The New York Times, Cars.com  is a digital marketplace that connects new and used car buyers and sellers.Best-known for its HIV and Hepatitis treatments, Gilead Sciences  is a biopharmaceutical company that discovers, develops, and commercializes innovative medicines.Scale is a double-e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/1-value-stock-exciting-potential-130100749.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CARS","GILD","LU0289739699.SGD","BK4532","BK4583","LU1571399168.USD","BK4139","LU0320765992.SGD","IE00BKVL7J92.USD","LU1585245621.USD","LU1066053197.SGD","LU2087621335.USD","LU2089984988.USD","LU1430594728.SGD","BK4585","BK4588","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","BK4129","IE00B19Z3581.USD","BK4578","LU1839511570.USD","LU0109394709.USD","GVA","LU0058720904.USD","BK4077","BK4568","LU2468319806.SGD","IE0002270589.USD","LU1066051498.USD","BK4566","BK4550","LU0889565916.HKD","IE00B3T34201.USD","LU0234570918.USD"],"gpt_icon":1},{"id":"2517448646","title":"Krystal Biotech Rises 15.8% in a Month: Should You Buy Now or Wait?","url":"https://stock-news.laohu8.com/highlight/detail?id=2517448646","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517448646?lang=en_us&edition=fundamental","pubTime":"2025-03-08 16:37","pubTimestamp":1741423020,"startTime":"0","endTime":"0","summary":"Shares of Krystal Biotech KRYS have gained 15.8% in the past month compared with the industry’s growth of 4%. The stock has also outperformed the industry and the sector in this timeframe.Last month, KRYS reported fourth-quarter 2024 results. While earnings beat estimates, sales missed the same. Nonetheless, shares surged post the quarterly release, mostly due to the strong uptake of Vyjuvek and encouraging pipeline progress.Krystal recorded Vyjuvek sales of $290.5 million, up from $50.7 million in 2023.It has made steady progress, securing access and reimbursement for Vyjuvek since its launch in the United States.As of February 2025, Krystal secured more than 510 reimbursement approvals for Vyjuvek in the United States and continues to maintain strong access nationwide, including positive access determinations for 97% of lives covered under commercial and Medicaid plans.Krystal is looking to get Vyjuvek approved in other geographies as well.In October, Krystal Biotech filed a new drug","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/krystal-biotech-rises-15-8-083700261.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0889565916.HKD","BK4585","LU1585245621.USD","LU1571399168.USD","IE00B19Z3B42.SGD","BK4566","IE00B3T34201.USD","IE00B7SZLL34.SGD","BK4588","BK4532","LU2468319806.SGD","LU1430594728.SGD","LU2089984988.USD","LU1839511570.USD","LU0109394709.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","BK4568","KRYS","IE0002270589.USD","BK4550","LU2087621335.USD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","BK4583","LU1066053197.SGD","LU0289739699.SGD","GILD","BK4139","BK4578","BMRN","LU0320765992.SGD","LU1066051498.USD","LU0234570918.USD"],"gpt_icon":0},{"id":"2517469334","title":"Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2517469334","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517469334?lang=en_us&edition=fundamental","pubTime":"2025-03-08 05:35","pubTimestamp":1741383300,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 1.18% to $117.41 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.55% to 5,770.20 and the Dow Jones Industrial Average  rising 0.52% to 42,801.72.This was the stock's third consecutive day of gains.Gilead Sciences Inc. hit a new 52-week high, surpassing its previous peak of $117.39, which the company reached on March 4th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.52% to $166.69, Pfizer Inc.  rose 1.87% to $26.73, and Abbott Laboratories  rose 1.53% to $137.14.Trading volume  eclipsed its 50-day average volume of 7.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 7, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independent","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD"],"gpt_icon":0},{"id":"2517464657","title":"Buy Gilead Sciences (GILD) Stock at 52-Week Highs?","url":"https://stock-news.laohu8.com/highlight/detail?id=2517464657","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517464657?lang=en_us&edition=fundamental","pubTime":"2025-03-08 04:54","pubTimestamp":1741380840,"startTime":"0","endTime":"0","summary":"Medical pioneer Gilead Sciences GILDhas seen its stock etch out new 52-week highs as the broader market pulled back sharply in recent weeks. Gilead has joined Johnson & Johnson JNJ, and a cluster of healthcare stocks that have risen to fresh peaks.This makes it a worthy topic of whether Gilead’s stock can reach higher highs with investors scoping out exposure to the medical sector amid economic uncertainty. Trading at $117 a share, GILD has spiked nearly +30% year to date with the broader market indexes in negative territory.Bringing in $28.75 billion in 2024, Gilead’s top line is expected to dip 1% this year but is projected to rebound and rise 4% in fiscal 2026 to $29.7 billion.More intriguing, Gilead’s operational efficiency has led the company and its stock back to prominence. Gilead’s annual earnings are expected to soar 70% in FY25 to $7.87 per share compared to EPS of $4.62 last year. Plus, FY26 EPS is projected to increase another 5%.Gilead Sciences, Inc.  : Free Stock Analysis","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/buy-gilead-sciences-gild-stock-205400778.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1430594728.SGD","LU1057294990.SGD","LU1585245621.USD","SG9999002232.USD","LU2430703095.HKD","BK4568","LU1061106388.HKD","JNJ","LU1506573853.SGD","LU0234572021.USD","LU0234570918.USD","BK4139","LU0792757196.USD","BK4585","LU0345769631.USD","BK4559","LU2087621335.USD","BK4588","LU0203347892.USD","LU0122379950.USD","LU2133065610.SGD","BK4534","LU1244550494.USD","IE00B7SZLL34.SGD","GILD","LU1929549753.HKD","LU0345770993.USD","LU1778281490.HKD","LU2430703251.USD","SG9999002224.SGD","IE00BKVL7J92.USD","LU0345769128.USD","LU2112291526.USD","IE00BDGV0183.EUR","IE000M9KFDE8.USD","LU1032955483.USD","IE0034235303.USD","BK4566","LU1894683264.USD","BK4007","BK4583","LU2089984988.USD","LU1894683348.USD","LU0058720904.USD","BK4550","LU2505996681.GBP","LU1674673428.USD","LU1914381329.SGD","BK4532","LU1732800096.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GILD\",params:#limit:5,,,undefined,":[{"date":"2025-04-24","symbol":"GILD","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":1.75,"defaultRemindTime":1745524800000,"name":null,"time":"Post Market","dateTimestamp":1745467200000,"actualEps":null},{"date":"2025-03-14","symbol":"GILD","amount":0.79,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-14","defaultRemindTime":1741959000000,"name":"吉利德科学","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-14","currency":"USD","dateTimestamp":1741924800000,"payDate":"2025-03-28"},{"market":"US","date":"2025-02-11","symbol":"GILD","fiscalQuarterEnding":"2024/12","expectedEps":1.67,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739250000000,"reportTimeType":"post","actualEps":1.9},{"date":"2024-12-13","symbol":"GILD","amount":0.77,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"吉利德科学","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-30"},{"market":"US","date":"2024-11-06","symbol":"GILD","fiscalQuarterEnding":"2024/09","expectedEps":1.58,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":2.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GILD\",market:\"US\",,,undefined,":[{"executeDate":"2015-06-12","recordDate":"2015-06-16","paymentDate":"2015-06-29","value":0.43,"currency":"USD"},{"executeDate":"2015-09-14","recordDate":"2015-09-16","paymentDate":"2015-09-29","value":0.43,"currency":"USD"},{"executeDate":"2015-12-14","recordDate":"2015-12-16","paymentDate":"2015-12-30","value":0.43,"currency":"USD"},{"executeDate":"2016-03-14","recordDate":"2016-03-16","paymentDate":"2016-03-30","value":0.43,"currency":"USD"},{"executeDate":"2016-06-14","recordDate":"2016-06-16","paymentDate":"2016-06-29","value":0.47,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GILD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.3333,"hold":0.3667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":30,"updateTime":1742443200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GILD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GILD","date":"2025-04-23","current":274.025839,"percent":0.822041,"low":-353.030459,"twenty":16.17325,"median":19.275171,"eighty":175.935023,"high":985.638037,"avg":115.862764,"sd":257.30769,"marketCap":131532402824},"quantilePoints":[{"date":"2020-04-24","current":18.616407,"twenty":6.427197,"median":14.646819,"eighty":30.203766,"marketCap":100267968138},{"date":"2020-05-01","current":20.205018,"twenty":6.427197,"median":14.646819,"eighty":30.040279,"marketCap":100257300000},{"date":"2020-05-08","current":19.589157,"twenty":6.427197,"median":14.646819,"eighty":29.863518,"marketCap":97201394766},{"date":"2020-05-15","current":19.278218,"twenty":6.427197,"median":14.646819,"eighty":29.6922,"marketCap":95658515484},{"date":"2020-05-22","current":18.540053,"twenty":6.427197,"median":14.646819,"eighty":29.202205,"marketCap":91995745156},{"date":"2020-05-29","current":19.675107,"twenty":6.427197,"median":14.646819,"eighty":29.042662,"marketCap":97627881722},{"date":"2020-06-05","current":19.402088,"twenty":6.427197,"median":14.646819,"eighty":28.831708,"marketCap":96273158450},{"date":"2020-06-12","current":18.504662,"twenty":6.427197,"median":14.646819,"eighty":27.315326,"marketCap":91820132880},{"date":"2020-06-19","current":19.584101,"twenty":6.427197,"median":14.646819,"eighty":26.917351,"marketCap":97176307298},{"date":"2020-06-26","current":18.850992,"twenty":6.427197,"median":14.646819,"eighty":26.756696,"marketCap":93538624438},{"date":"2020-07-02","current":19.300969,"twenty":6.427197,"median":14.646819,"eighty":26.63808,"marketCap":95771409090},{"date":"2020-07-10","current":19.293385,"twenty":6.427197,"median":14.646819,"eighty":26.355806,"marketCap":95733777888},{"date":"2020-07-17","current":19.594212,"twenty":6.427197,"median":14.646819,"eighty":25.598322,"marketCap":97226482234},{"date":"2020-07-24","current":18.615892,"twenty":6.427197,"median":14.646819,"eighty":25.376857,"marketCap":92372057176},{"date":"2020-07-31","current":-339.364134,"twenty":6.410323,"median":14.629784,"eighty":25.277011,"marketCap":87216582502},{"date":"2020-08-07","current":-338.310448,"twenty":6.392142,"median":14.560725,"eighty":25.150137,"marketCap":86945785059},{"date":"2020-08-14","current":-334.163889,"twenty":6.380126,"median":14.488429,"eighty":25.150137,"marketCap":85880119345},{"date":"2020-08-21","current":-324.407279,"twenty":6.34887,"median":14.451741,"eighty":25.150137,"marketCap":83372670605},{"date":"2020-08-28","current":-318.35818,"twenty":6.326168,"median":14.415069,"eighty":25.150137,"marketCap":81818052386},{"date":"2020-09-04","current":-322.016909,"twenty":6.300695,"median":14.353547,"eighty":25.150137,"marketCap":82758345663},{"date":"2020-09-11","current":-319.919238,"twenty":6.282152,"median":14.321176,"eighty":25.150137,"marketCap":82219244184},{"date":"2020-09-18","current":-317.333736,"twenty":6.244206,"median":14.279358,"eighty":25.150137,"marketCap":81554770268},{"date":"2020-09-25","current":-303.674483,"twenty":6.163333,"median":14.261828,"eighty":25.150137,"marketCap":78044342032},{"date":"2020-10-02","current":-303.284218,"twenty":6.038611,"median":14.169569,"eighty":25.150137,"marketCap":77944044082},{"date":"2020-10-09","current":-311.430987,"twenty":5.952564,"median":14.135621,"eighty":25.150137,"marketCap":80037763780},{"date":"2020-10-16","current":-302.454906,"twenty":5.912527,"median":14.104836,"eighty":25.150137,"marketCap":77730910940},{"date":"2020-10-23","current":-296.552157,"twenty":5.894484,"median":14.057828,"eighty":25.150137,"marketCap":76213904452},{"date":"2020-10-30","current":57.495325,"twenty":5.887283,"median":14.035041,"eighty":25.277011,"marketCap":72904072115},{"date":"2020-11-06","current":58.395826,"twenty":5.887283,"median":14.035041,"eighty":25.376857,"marketCap":74045907761},{"date":"2020-11-13","current":59.893535,"twenty":5.887283,"median":14.035041,"eighty":25.598322,"marketCap":75945002907},{"date":"2020-11-20","current":59.423957,"twenty":5.887283,"median":14.035041,"eighty":26.355806,"marketCap":75349577036},{"date":"2020-11-27","current":59.34487,"twenty":5.887283,"median":14.035041,"eighty":26.598291,"marketCap":75249294784},{"date":"2020-12-04","current":60.857408,"twenty":5.887283,"median":14.035041,"eighty":26.756696,"marketCap":77167192852},{"date":"2020-12-11","current":60.066538,"twenty":5.887283,"median":14.035041,"eighty":26.917351,"marketCap":76164370333},{"date":"2020-12-18","current":58.405712,"twenty":5.887283,"median":14.035041,"eighty":27.315326,"marketCap":74058443042},{"date":"2020-12-24","current":56.418653,"twenty":5.887283,"median":14.035041,"eighty":28.776154,"marketCap":71538851463},{"date":"2020-12-31","current":57.595071,"twenty":5.887283,"median":14.035041,"eighty":28.982603,"marketCap":73030549960},{"date":"2021-01-08","current":62.320516,"twenty":5.887283,"median":14.035041,"eighty":29.131999,"marketCap":79022414512},{"date":"2021-01-15","current":62.607206,"twenty":5.887283,"median":14.035041,"eighty":29.690755,"marketCap":79385937676},{"date":"2021-01-22","current":66.176005,"twenty":5.887283,"median":14.071576,"eighty":29.782104,"marketCap":83911174294},{"date":"2021-01-29","current":64.851299,"twenty":5.887283,"median":14.109654,"eighty":29.979206,"marketCap":82231446574},{"date":"2021-02-05","current":697.695423,"twenty":5.887283,"median":14.148779,"eighty":30.122962,"marketCap":85816537080},{"date":"2021-02-12","current":681.695105,"twenty":5.887283,"median":14.235931,"eighty":30.220678,"marketCap":83848497886},{"date":"2021-02-19","current":656.013065,"twenty":5.887283,"median":14.27046,"eighty":30.484701,"marketCap":80689606951},{"date":"2021-02-26","current":627.274958,"twenty":5.887283,"median":14.306069,"eighty":30.569263,"marketCap":77154819778},{"date":"2021-03-05","current":660.171136,"twenty":5.886815,"median":14.351389,"eighty":30.669098,"marketCap":81201049740},{"date":"2021-03-12","current":628.90955,"twenty":5.886815,"median":14.411816,"eighty":30.847379,"marketCap":77355874683},{"date":"2021-03-19","current":658.536543,"twenty":5.886815,"median":14.446346,"eighty":30.947914,"marketCap":80999994835},{"date":"2021-03-26","current":666.505183,"twenty":5.887283,"median":14.479757,"eighty":31.062543,"marketCap":81980137497},{"date":"2021-04-01","current":680.094988,"twenty":5.887283,"median":14.515798,"eighty":31.220392,"marketCap":83651683496},{"date":"2021-04-09","current":666.480805,"twenty":5.886815,"median":14.621022,"eighty":31.471261,"marketCap":81977138959},{"date":"2021-04-16","current":684.496566,"twenty":5.886815,"median":14.653082,"eighty":31.596225,"marketCap":84193077595},{"date":"2021-04-23","current":670.268209,"twenty":5.886815,"median":14.712213,"eighty":42.207393,"marketCap":82442989695},{"date":"2021-04-30","current":265.489326,"twenty":5.886815,"median":14.778694,"eighty":42.567879,"marketCap":79912287049},{"date":"2021-05-07","current":277.252542,"twenty":5.886815,"median":14.856386,"eighty":42.894314,"marketCap":83453015165},{"date":"2021-05-14","current":285.544285,"twenty":5.886815,"median":14.904321,"eighty":43.205482,"marketCap":85948829715},{"date":"2021-05-21","current":286.46096,"twenty":5.886815,"median":15.044244,"eighty":43.463811,"marketCap":86224748912},{"date":"2021-05-28","current":275.460859,"twenty":5.886815,"median":15.158818,"eighty":43.913538,"marketCap":82913718554},{"date":"2021-06-04","current":280.960909,"twenty":5.886815,"median":15.193582,"eighty":44.006301,"marketCap":84569233733},{"date":"2021-06-11","current":286.544294,"twenty":5.886815,"median":15.256684,"eighty":44.397317,"marketCap":86249832475},{"date":"2021-06-18","current":277.544211,"twenty":5.886815,"median":15.331847,"eighty":44.793017,"marketCap":83540807637},{"date":"2021-06-25","current":282.835927,"twenty":5.886815,"median":15.396911,"eighty":44.953898,"marketCap":85133613908},{"date":"2021-07-02","current":288.752648,"twenty":5.886815,"median":15.472548,"eighty":45.316733,"marketCap":86914546903},{"date":"2021-07-09","current":284.252606,"twenty":5.886815,"median":15.579206,"eighty":45.697022,"marketCap":85560034484},{"date":"2021-07-16","current":285.960955,"twenty":5.886815,"median":15.726234,"eighty":45.841484,"marketCap":86074247532},{"date":"2021-07-23","current":287.58597,"twenty":5.886815,"median":15.752152,"eighty":47.568365,"marketCap":86563377017},{"date":"2021-07-30","current":16.591985,"twenty":5.886815,"median":15.856378,"eighty":51.009533,"marketCap":85647826956},{"date":"2021-08-06","current":16.706124,"twenty":5.886815,"median":15.9165,"eighty":51.009533,"marketCap":86237013283},{"date":"2021-08-13","current":17.284208,"twenty":5.886815,"median":16.177233,"eighty":51.009533,"marketCap":89221079750},{"date":"2021-08-20","current":17.59511,"twenty":5.886815,"median":16.446515,"eighty":51.009533,"marketCap":90825955833},{"date":"2021-08-27","current":17.313355,"twenty":5.886815,"median":16.628399,"eighty":51.009533,"marketCap":89371536883},{"date":"2021-09-03","current":17.478521,"twenty":5.886815,"median":16.94972,"eighty":51.009533,"marketCap":90224127302},{"date":"2021-09-10","current":17.242916,"twenty":5.886815,"median":16.972053,"eighty":51.009533,"marketCap":89007932145},{"date":"2021-09-17","current":17.393509,"twenty":5.886815,"median":17.123861,"eighty":51.009533,"marketCap":89785293998},{"date":"2021-09-24","current":17.291494,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":89258694033},{"date":"2021-10-01","current":16.652688,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":85961175206},{"date":"2021-10-08","current":16.528813,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":85321732392},{"date":"2021-10-15","current":16.426798,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":84795132427},{"date":"2021-10-22","current":16.33207,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":84306146745},{"date":"2021-10-29","current":11.012226,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":81424400000},{"date":"2021-11-05","current":11.251111,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":83190715179},{"date":"2021-11-12","current":11.447904,"twenty":5.893685,"median":17.235629,"eighty":51.009533,"marketCap":84645800064},{"date":"2021-11-19","current":11.653179,"twenty":5.897479,"median":17.235629,"eighty":51.009533,"marketCap":86163604126},{"date":"2021-11-26","current":11.921224,"twenty":5.918211,"median":17.235629,"eighty":51.009533,"marketCap":88145530090},{"date":"2021-12-03","current":11.800773,"twenty":6.026147,"median":17.235629,"eighty":51.009533,"marketCap":87254917790},{"date":"2021-12-10","current":11.917831,"twenty":6.210409,"median":17.235629,"eighty":51.009533,"marketCap":88120442420},{"date":"2021-12-17","current":12.250343,"twenty":6.275567,"median":17.235629,"eighty":51.009533,"marketCap":90579034123},{"date":"2021-12-23","current":12.296148,"twenty":6.286831,"median":17.235629,"eighty":51.009533,"marketCap":90917717674},{"date":"2021-12-31","current":12.318202,"twenty":6.311092,"median":17.235629,"eighty":51.009533,"marketCap":91080787532},{"date":"2022-01-07","current":12.089176,"twenty":6.331714,"median":17.2332,"eighty":50.998121,"marketCap":89387369777},{"date":"2022-01-14","current":12.175697,"twenty":6.376154,"median":17.2332,"eighty":50.998121,"marketCap":90027105373},{"date":"2022-01-21","current":11.622642,"twenty":6.392142,"median":17.2332,"eighty":50.998121,"marketCap":85937815092},{"date":"2022-01-28","current":11.682019,"twenty":6.427197,"median":17.2332,"eighty":50.998121,"marketCap":86376849324},{"date":"2022-02-04","current":12.876322,"twenty":6.478068,"median":17.2332,"eighty":50.998121,"marketCap":80155107055},{"date":"2022-02-11","current":12.507564,"twenty":6.506803,"median":17.2332,"eighty":50.998121,"marketCap":77859585210},{"date":"2022-02-18","current":12.302026,"twenty":6.55983,"median":17.2332,"eighty":50.998121,"marketCap":76580114018},{"date":"2022-02-25","current":12.311254,"twenty":6.578904,"median":17.2332,"eighty":50.998121,"marketCap":76637556570},{"date":"2022-03-04","current":12.46031,"twenty":6.599937,"median":17.2332,"eighty":50.998121,"marketCap":77565432746},{"date":"2022-03-11","current":11.6828,"twenty":6.635114,"median":17.2332,"eighty":50.998121,"marketCap":72725429992},{"date":"2022-03-18","current":11.968827,"twenty":6.678391,"median":17.2332,"eighty":50.998121,"marketCap":74505949140},{"date":"2022-03-25","current":11.884082,"twenty":6.698205,"median":17.2332,"eighty":50.998121,"marketCap":73978409872},{"date":"2022-04-01","current":12.037399,"twenty":8.02258,"median":17.2332,"eighty":50.998121,"marketCap":74932807962},{"date":"2022-04-08","current":12.567956,"twenty":8.716567,"median":17.2332,"eighty":50.998121,"marketCap":78235527670},{"date":"2022-04-14","current":12.471124,"twenty":8.90123,"median":17.2332,"eighty":50.998121,"marketCap":77632749929},{"date":"2022-04-22","current":12.55787,"twenty":9.141519,"median":17.2332,"eighty":50.998121,"marketCap":78172738322},{"date":"2022-04-29","current":16.504629,"twenty":9.361538,"median":17.2332,"eighty":50.998121,"marketCap":74518398265},{"date":"2022-05-06","current":16.996433,"twenty":10.809551,"median":17.239272,"eighty":50.998121,"marketCap":76738896748},{"date":"2022-05-13","current":17.327028,"twenty":11.245343,"median":17.247681,"eighty":50.998121,"marketCap":78231529751},{"date":"2022-05-20","current":17.735409,"twenty":11.419063,"median":17.289789,"eighty":50.998121,"marketCap":80075370520},{"date":"2022-05-27","current":18.002107,"twenty":11.443493,"median":17.319427,"eighty":50.998121,"marketCap":81279511430},{"date":"2022-06-03","current":17.627063,"twenty":11.598891,"median":17.34736,"eighty":50.998121,"marketCap":79586188275},{"date":"2022-06-10","current":16.874197,"twenty":11.674743,"median":17.353688,"eighty":50.998121,"marketCap":76186998831},{"date":"2022-06-17","current":16.260236,"twenty":11.693895,"median":17.353688,"eighty":50.998121,"marketCap":73414966111},{"date":"2022-06-24","current":17.524273,"twenty":11.796701,"median":17.385368,"eighty":51.009533,"marketCap":79122092299},{"date":"2022-07-01","current":17.32425,"twenty":11.863803,"median":17.393509,"eighty":51.009533,"marketCap":78218986617},{"date":"2022-07-08","current":17.457598,"twenty":11.905616,"median":17.41294,"eighty":51.009533,"marketCap":78821057072},{"date":"2022-07-15","current":17.390924,"twenty":11.935322,"median":17.41294,"eighty":51.009533,"marketCap":78520021844},{"date":"2022-07-22","current":16.890865,"twenty":11.980941,"median":17.41294,"eighty":51.009533,"marketCap":76262257638},{"date":"2022-07-29","current":16.599165,"twenty":12.028097,"median":17.41294,"eighty":51.009533,"marketCap":74945228518},{"date":"2022-08-05","current":18.52212,"twenty":12.086156,"median":17.427039,"eighty":51.009533,"marketCap":76626008538},{"date":"2022-08-12","current":19.074694,"twenty":12.171909,"median":17.456661,"eighty":51.009533,"marketCap":78912011126},{"date":"2022-08-19","current":19.795752,"twenty":12.222347,"median":17.478521,"eighty":51.009533,"marketCap":81895025523},{"date":"2022-08-26","current":18.895945,"twenty":12.254415,"median":17.529437,"eighty":51.009533,"marketCap":78172524363},{"date":"2022-09-02","current":19.335245,"twenty":12.287819,"median":17.577057,"eighty":51.009533,"marketCap":79989907085},{"date":"2022-09-09","current":19.777574,"twenty":12.303022,"median":17.627063,"eighty":51.009533,"marketCap":81819823480},{"date":"2022-09-16","current":19.874523,"twenty":12.328536,"median":17.735409,"eighty":51.009533,"marketCap":82220901046},{"date":"2022-09-23","current":19.044398,"twenty":12.37249,"median":17.877092,"eighty":51.009533,"marketCap":78786674386},{"date":"2022-09-30","current":18.689929,"twenty":12.440381,"median":18.002107,"eighty":51.009533,"marketCap":77320234535},{"date":"2022-10-07","current":19.477638,"twenty":12.472434,"median":18.174606,"eighty":51.009533,"marketCap":80578989760},{"date":"2022-10-14","current":20.047213,"twenty":12.542538,"median":18.389663,"eighty":51.009533,"marketCap":82935320460},{"date":"2022-10-21","current":20.538017,"twenty":12.806741,"median":18.504662,"eighty":51.009533,"marketCap":84965775639},{"date":"2022-10-28","current":29.80037,"twenty":13.013399,"median":18.615892,"eighty":51.009533,"marketCap":99354433322},{"date":"2022-11-04","current":30.22374,"twenty":13.251735,"median":18.662662,"eighty":51.009533,"marketCap":100765950507},{"date":"2022-11-11","current":30.780513,"twenty":13.37445,"median":18.717011,"eighty":51.009533,"marketCap":102622231397},{"date":"2022-11-18","current":31.45767,"twenty":13.431735,"median":18.843409,"eighty":51.009533,"marketCap":104879870318},{"date":"2022-11-25","current":32.450832,"twenty":13.459519,"median":18.879888,"eighty":51.009533,"marketCap":108191074069},{"date":"2022-12-02","current":33.4929,"twenty":13.504605,"median":18.899024,"eighty":51.009533,"marketCap":111665329520},{"date":"2022-12-09","current":33.09413,"twenty":13.606687,"median":18.972334,"eighty":51.009533,"marketCap":110335831044},{"date":"2022-12-16","current":32.638931,"twenty":13.64752,"median":19.040589,"eighty":51.009533,"marketCap":108818195992},{"date":"2022-12-23","current":31.882773,"twenty":13.702003,"median":19.108021,"eighty":51.009533,"marketCap":106297165863},{"date":"2022-12-30","current":32.296591,"twenty":13.772637,"median":19.194795,"eighty":51.009533,"marketCap":107676834093},{"date":"2023-01-06","current":33.135512,"twenty":13.805022,"median":19.238296,"eighty":51.009533,"marketCap":110473797867},{"date":"2023-01-13","current":32.454594,"twenty":13.873802,"median":19.29283,"eighty":51.009533,"marketCap":108203616508},{"date":"2023-01-20","current":31.228189,"twenty":13.90331,"median":19.320096,"eighty":51.009533,"marketCap":104114781573},{"date":"2023-01-27","current":31.499051,"twenty":13.995449,"median":19.384392,"eighty":51.009533,"marketCap":105017837141},{"date":"2023-02-03","current":22.946755,"twenty":14.041486,"median":19.450119,"eighty":51.009533,"marketCap":105371500000},{"date":"2023-02-10","current":23.544186,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":108114900000},{"date":"2023-02-17","current":23.017361,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":105695720000},{"date":"2023-02-24","current":21.905815,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":100591501721},{"date":"2023-03-03","current":22.017164,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":101102814834},{"date":"2023-03-10","current":21.59078,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":99144859743},{"date":"2023-03-17","current":20.996015,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":96413699455},{"date":"2023-03-24","current":21.756377,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":99905284240},{"date":"2023-03-31","current":22.564083,"twenty":14.066937,"median":19.46767,"eighty":50.998121,"marketCap":103614267917},{"date":"2023-04-06","current":22.749012,"twenty":14.066937,"median":19.46767,"eighty":50.998121,"marketCap":104463462833},{"date":"2023-04-14","current":22.645669,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":103988912733},{"date":"2023-04-21","current":23.031845,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":105762231528},{"date":"2023-04-28","current":18.688623,"twenty":14.055938,"median":19.442338,"eighty":51.020944,"marketCap":104338581228},{"date":"2023-05-05","current":17.542922,"twenty":14.055938,"median":19.3806,"eighty":51.020944,"marketCap":97942133140},{"date":"2023-05-12","current":17.583137,"twenty":14.055938,"median":19.319381,"eighty":51.020944,"marketCap":98166656624},{"date":"2023-05-19","current":17.473662,"twenty":14.050438,"median":19.278218,"eighty":51.032356,"marketCap":97555453806},{"date":"2023-05-26","current":17.348547,"twenty":14.044939,"median":19.233751,"eighty":51.043768,"marketCap":96856936300},{"date":"2023-06-02","current":17.026822,"twenty":14.044939,"median":19.162011,"eighty":51.043768,"marketCap":95060748428},{"date":"2023-06-08","current":16.997778,"twenty":14.044939,"median":19.104641,"eighty":51.043768,"marketCap":94898592579},{"date":"2023-06-16","current":17.650163,"twenty":14.039759,"median":19.040589,"eighty":51.200274,"marketCap":98540862431},{"date":"2023-06-23","current":17.45132,"twenty":14.038033,"median":18.973525,"eighty":51.252442,"marketCap":97430718537},{"date":"2023-06-30","current":16.982138,"twenty":14.036306,"median":18.920182,"eighty":51.304611,"marketCap":94811277890},{"date":"2023-07-07","current":17.033525,"twenty":14.036306,"median":18.886384,"eighty":51.304611,"marketCap":95098169009},{"date":"2023-07-14","current":17.138532,"twenty":14.036306,"median":18.848464,"eighty":51.304611,"marketCap":95684424773},{"date":"2023-07-21","current":17.860178,"twenty":14.036306,"median":18.770739,"eighty":51.304611,"marketCap":99713373958},{"date":"2023-07-28","current":17.093848,"twenty":14.036306,"median":18.679091,"eighty":51.304611,"marketCap":95434954235},{"date":"2023-08-04","current":17.179531,"twenty":14.036306,"median":18.633127,"eighty":51.304611,"marketCap":94212548600},{"date":"2023-08-11","current":18.176723,"twenty":14.036306,"median":18.52212,"eighty":51.304611,"marketCap":99681148240},{"date":"2023-08-18","current":17.381491,"twenty":14.036306,"median":18.429012,"eighty":51.304611,"marketCap":95320098004},{"date":"2023-08-25","current":17.342866,"twenty":14.036306,"median":18.328953,"eighty":51.304611,"marketCap":95108275564},{"date":"2023-09-01","current":17.376947,"twenty":14.036306,"median":18.1949,"eighty":51.304611,"marketCap":95295177717},{"date":"2023-09-08","current":16.799836,"twenty":14.036306,"median":18.174606,"eighty":51.304611,"marketCap":92130301260},{"date":"2023-09-15","current":17.576891,"twenty":14.036306,"median":18.052169,"eighty":51.304611,"marketCap":96391670348},{"date":"2023-09-22","current":17.102024,"twenty":14.036306,"median":17.993772,"eighty":51.304611,"marketCap":93787500350},{"date":"2023-09-29","current":17.136105,"twenty":14.036306,"median":17.876807,"eighty":51.304611,"marketCap":93974402503},{"date":"2023-10-06","current":16.972515,"twenty":14.036306,"median":17.771527,"eighty":51.304611,"marketCap":93077272169},{"date":"2023-10-13","current":17.440566,"twenty":14.036306,"median":17.722305,"eighty":51.304611,"marketCap":95644061736},{"date":"2023-10-19","current":18.101744,"twenty":14.036306,"median":17.689975,"eighty":51.304611,"marketCap":99269963503},{"date":"2023-10-27","current":17.835909,"twenty":14.029482,"median":17.676863,"eighty":51.032356,"marketCap":97812126710},{"date":"2023-11-03","current":18.45619,"twenty":14.029482,"median":17.650163,"eighty":33.471833,"marketCap":101213745894},{"date":"2023-11-10","current":15.89997,"twenty":14.029482,"median":17.641227,"eighty":33.09714,"marketCap":93428221287},{"date":"2023-11-17","current":15.802424,"twenty":14.029482,"median":17.615533,"eighty":32.981271,"marketCap":92855042015},{"date":"2023-11-24","current":15.984792,"twenty":14.029482,"median":17.59511,"eighty":32.559177,"marketCap":93926638045},{"date":"2023-12-01","current":16.243501,"twenty":14.029482,"median":17.57082,"eighty":32.289819,"marketCap":95446809157},{"date":"2023-12-08","current":16.550982,"twenty":14.031188,"median":17.55419,"eighty":32.133321,"marketCap":97253569904},{"date":"2023-12-15","current":17.341951,"twenty":14.031188,"median":17.52836,"eighty":32.07012,"marketCap":101901306173},{"date":"2023-12-22","current":16.737591,"twenty":14.031188,"median":17.504184,"eighty":31.887287,"marketCap":98350086772},{"date":"2023-12-29","current":17.206235,"twenty":14.029482,"median":17.486007,"eighty":31.764,"marketCap":101103839360},{"date":"2024-01-05","current":17.914503,"twenty":14.027776,"median":17.48476,"eighty":31.6075,"marketCap":105265619289},{"date":"2024-01-12","current":18.107474,"twenty":14.027776,"median":17.48476,"eighty":31.532333,"marketCap":106399517414},{"date":"2024-01-19","current":18.321651,"twenty":14.024373,"median":17.483513,"eighty":31.465946,"marketCap":107658019728},{"date":"2024-01-26","current":17.013264,"twenty":14.027776,"median":17.475784,"eighty":31.443073,"marketCap":99969941235},{"date":"2024-02-02","current":16.574308,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":97390634513},{"date":"2024-02-09","current":16.232638,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":91957891851},{"date":"2024-02-16","current":16.138057,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":91422093836},{"date":"2024-02-23","current":16.008284,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":90686929118},{"date":"2024-03-01","current":15.855313,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":89820349813},{"date":"2024-03-08","current":16.198369,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":91763758214},{"date":"2024-03-15","current":16.319318,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":92448934253},{"date":"2024-03-22","current":16.073021,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":91053666683},{"date":"2024-03-28","current":16.055429,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":90954004714},{"date":"2024-04-05","current":15.309217,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":86726715023},{"date":"2024-04-12","current":15.111111,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":85604442650},{"date":"2024-04-19","current":14.563017,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":82499489086},{"date":"2024-04-26","current":167.813786,"twenty":14.029482,"median":17.45909,"eighty":31.35376,"marketCap":81389686406},{"date":"2024-05-03","current":167.968051,"twenty":14.029482,"median":17.475896,"eighty":31.454751,"marketCap":81464504564},{"date":"2024-05-10","current":165.891135,"twenty":14.029482,"median":17.490666,"eighty":31.502061,"marketCap":80457200237},{"date":"2024-05-17","current":174.305702,"twenty":14.043532,"median":17.524273,"eighty":31.57906,"marketCap":84538265441},{"date":"2024-05-24","current":169.975478,"twenty":14.043532,"median":17.54896,"eighty":31.623197,"marketCap":82438106839},{"date":"2024-05-31","current":164.60675,"twenty":14.10774,"median":17.565264,"eighty":31.836928,"marketCap":79834273632},{"date":"2024-06-07","current":164.015933,"twenty":14.265245,"median":17.579161,"eighty":32.047548,"marketCap":79547727394},{"date":"2024-06-14","current":163.27099,"twenty":14.274228,"median":17.606597,"eighty":32.082158,"marketCap":79186429964},{"date":"2024-06-21","current":175.935023,"twenty":14.272576,"median":17.621828,"eighty":32.181475,"marketCap":85328486284},{"date":"2024-06-28","current":176.808405,"twenty":14.267619,"median":17.642004,"eighty":32.289819,"marketCap":85752076375},{"date":"2024-07-05","current":171.054361,"twenty":14.267619,"median":17.658975,"eighty":32.499738,"marketCap":82961365187},{"date":"2024-07-12","current":179.736802,"twenty":14.267619,"median":17.687689,"eighty":32.981271,"marketCap":87172349033},{"date":"2024-07-15","current":179.711114,"twenty":14.267619,"median":17.696211,"eighty":33.038453,"marketCap":87159890501},{"date":"2024-08-02","current":196.485179,"twenty":14.529265,"median":17.810595,"eighty":33.095635,"marketCap":95295311956},{"date":"2024-08-09","current":89.28743,"twenty":14.761123,"median":17.860178,"eighty":33.429699,"marketCap":94108951402},{"date":"2024-08-16","current":87.810922,"twenty":15.064446,"median":17.910429,"eighty":56.284205,"marketCap":92552711301},{"date":"2024-08-23","current":89.653604,"twenty":15.441554,"median":17.994613,"eighty":57.705461,"marketCap":94494898947},{"date":"2024-08-30","current":93.846889,"twenty":15.739388,"median":18.052169,"eighty":58.207525,"marketCap":98914620835},{"date":"2024-09-06","current":93.043668,"twenty":15.813085,"median":18.107474,"eighty":58.39978,"marketCap":98068026220},{"date":"2024-09-13","current":98.229166,"twenty":15.851395,"median":18.176723,"eighty":59.168901,"marketCap":103533541455},{"date":"2024-09-20","current":99.10326,"twenty":15.88894,"median":18.219893,"eighty":59.37255,"marketCap":104454835595},{"date":"2024-09-27","current":98.087422,"twenty":15.920691,"median":18.287258,"eighty":59.81346,"marketCap":103384142406},{"date":"2024-10-04","current":99.422185,"twenty":15.979621,"median":18.356937,"eighty":60.090264,"marketCap":104790983457},{"date":"2024-10-11","current":100.012789,"twenty":16.007608,"median":18.435741,"eighty":60.321593,"marketCap":105413479498},{"date":"2024-10-18","current":103.190235,"twenty":16.047512,"median":18.510381,"eighty":60.845545,"marketCap":108762508196},{"date":"2024-10-25","current":104.867549,"twenty":16.062334,"median":18.540053,"eighty":61.800519,"marketCap":110530396951},{"date":"2024-10-31","current":104.288758,"twenty":16.062334,"median":18.540053,"eighty":63.846895,"marketCap":109920350831},{"date":"2024-11-08","current":968.122222,"twenty":16.060766,"median":18.539019,"eighty":65.503766,"marketCap":121983400000},{"date":"2024-11-15","current":911.059905,"twenty":16.060766,"median":18.539019,"eighty":67.314857,"marketCap":114793548088},{"date":"2024-11-22","current":887.816058,"twenty":16.060766,"median":18.539019,"eighty":87.499083,"marketCap":111864823324},{"date":"2024-11-29","current":915.708675,"twenty":16.060766,"median":18.539019,"eighty":88.564531,"marketCap":115379293041},{"date":"2024-12-06","current":923.720384,"twenty":16.060766,"median":18.539019,"eighty":90.934033,"marketCap":116388768385},{"date":"2024-12-13","current":913.730475,"twenty":16.060766,"median":18.539019,"eighty":93.40748,"marketCap":115130039869},{"date":"2024-12-20","current":900.971087,"twenty":16.060766,"median":18.539019,"eighty":95.961249,"marketCap":113522356914},{"date":"2024-12-27","current":933.809203,"twenty":16.060766,"median":18.539019,"eighty":98.094509,"marketCap":117659959559},{"date":"2025-01-03","current":908.784976,"twenty":16.060766,"median":18.539019,"eighty":98.88828,"marketCap":114506906941},{"date":"2025-01-10","current":881.683639,"twenty":16.059197,"median":18.537985,"eighty":99.141058,"marketCap":111092138492},{"date":"2025-01-17","current":906.510046,"twenty":16.059197,"median":18.537985,"eighty":99.880493,"marketCap":114220265794},{"date":"2025-01-24","current":919.071615,"twenty":16.059197,"median":18.537985,"eighty":100.438024,"marketCap":115803023432},{"date":"2025-01-31","current":958.93234,"twenty":16.059197,"median":18.537985,"eighty":102.332679,"marketCap":120825474836},{"date":"2025-02-07","current":969.713529,"twenty":16.09178,"median":18.615892,"eighty":104.116302,"marketCap":122183904620},{"date":"2025-02-14","current":275.113188,"twenty":16.111578,"median":18.662662,"eighty":105.609347,"marketCap":132054330207},{"date":"2025-02-21","current":285.680484,"twenty":16.147709,"median":18.689929,"eighty":162.793199,"marketCap":137126632245},{"date":"2025-02-28","current":290.769403,"twenty":16.147709,"median":18.808017,"eighty":164.216297,"marketCap":139569313325},{"date":"2025-03-07","current":301.06241,"twenty":16.143392,"median":18.87176,"eighty":165.27463,"marketCap":144509957034},{"date":"2025-03-14","current":294.083284,"twenty":16.164977,"median":18.897485,"eighty":166.913912,"marketCap":141159976127},{"date":"2025-03-21","current":274.676641,"twenty":16.17325,"median":18.953832,"eighty":167.968051,"marketCap":131844787583},{"date":"2025-03-28","current":288.401392,"twenty":16.17325,"median":19.023685,"eighty":168.716781,"marketCap":138432668251},{"date":"2025-04-04","current":291.592591,"twenty":16.17325,"median":19.104641,"eighty":171.054361,"marketCap":139964443908},{"date":"2025-04-11","current":263.079356,"twenty":16.173436,"median":19.194795,"eighty":173.515242,"marketCap":126278090686},{"date":"2025-04-17","current":272.389631,"twenty":16.173436,"median":19.238296,"eighty":174.142022,"marketCap":130747023108},{"date":"2025-04-23","current":274.025839,"twenty":16.17325,"median":19.275171,"eighty":175.935023,"marketCap":131532402824}],"updateTime":1745496991662}}}